Dr. Porth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Boston, MA 02215Phone+1 617-754-9600
Education & Training
- Tufts University School of MedicineClass of 2022
Certifications & Licensure
- MA State Medical License 2022 - 2026
Publications & Presentations
PubMed
- 2 citationsProactive Therapeutic Drug Monitoring Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease Treated With Intravenous Vedolizumab.Rachel Porth, Tina Deyhim, Samantha Zullow, Loren G Rabinowitz, Laurie B Grossberg
Inflammatory Bowel Diseases. 2025-02-06 - Proactive Therapeutic Drug Monitoring of Ustekinumab Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease.Rachel Porth, Tina Deyhim, Grace Geeganage, Brenden Smith, Samantha Zullow
Inflammatory Bowel Diseases. 2024-09-26 - The Role of Sodium-Glucose Cotransporter-2 Inhibitors in the Treatment of Polycystic Ovary Syndrome: A Review.Rachel Porth, Karina Oelerich, Mala S Sivanandy
Journal of Clinical Medicine. 2024-02-13
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: